Role and Containment of Asymptomatic Cases in COVID-19 Transmission

doi:10.12114/j.issn.1007-9572.2021.00.416

Abstract

Abstract: COVID-19 has been plaguing global health for nearly a year.During the past year，many governments took arious measures such as closing schools and office-buildings，imposing social distancing to cut off the virus' transmission route.However，in the gradual return to normality，asymptomatic patients will，and already have，pose grave challenges.This paper reviews the proportion of asymptomatic COVID-19 cases in the global population，the role these cases have played in the transmission，and measures to restrict COVID-19 transmission through asymptomatic cases.

Key words: Pneumonia, COVID-19, SARS-CoV-2, Asymptomatic carriers, Control

摘要： 新型冠状病毒肺炎（COVID-19）已在全球流行近一年，对世界人口健康造成巨大打击。许多国家为切断病毒传播途径，采取关闭学校和工作场所、强制公众保持社交距离等措施。在逐步恢复正常的工作和生活秩序过程中，无症状感染者对COVID-19流行的影响无疑是一个重要挑战。本文针对无症状感染者在人群中的比例、无症状感染者在传播中的作用以及限制无症状感染者造成的病毒传播等方面的研究进展进行综述。

关键词: 肺炎, 新型冠状病毒肺炎, 新型冠状病毒, 无症状感染者, 控制

LIU Qiao,LIU Jue,LIU Min. Role and Containment of Asymptomatic Cases in COVID-19 Transmission　[J]. Chinese General Practice, 2021, 24(8): 917-922. DOI: 10.12114/j.issn.1007-9572.2021.00.416.
刘巧,刘珏,刘民. 无症状感染者对COVID-19流行的影响及其防控措施研究[J]. 中国全科医学, 2021, 24(8): 917-922. DOI: 10.12114/j.issn.1007-9572.2021.00.416.

References

［1］WHO.Weekly epidemiological update-22 December 2020［EB/OL］．（2020-12-22）［2020-12-23］．https：//www.who.int/docs/default-source/coronaviruse/situation-reports/20201222_weekly_epi_update_19.pdf?sfvrsn=9ba3df9a_5&download=true.
［2］ROSER M，RITCHIE H，ORTIZ-OSPINA E，et al．Coronavirus Pandemic （COVID-19）［EB/OL］．［2020-12-23］．https：//ourworldindata.org/coronavirus.
［3］GANDHI M，YOKOE D S，HAVLIR D V.Asymptomatic transmission，the Achilles' heel of current strategies to control COVID-19［J］．N Engl J Med，2020，382（22）：2158-2160．DOI：10.1056/NEJMe2009758.
［4］国务院应对新型冠状病毒肺炎疫情联防联控机制综合组.新型冠状病毒肺炎防控方案（第七版）［EB/OL］．（2020-09-11）［2020-12-23］．http：//www.nhc.gov.cn/jkj/s3577/202009/318683cbfaee4191aee29cd774b19d8d/files/f9ea38ce2c2d4352bf61ab0feada439f.pdf.
［5］WHO.Coronavirus disease （COVID-19）：How is it transmitted?［EB/OL］．（2020-07-09）［2020-12-23］．https：//www.who.int/news-room/q-a-detail/coronavirus-disease-covid-19-how-is-it-transmitted.
［6］OOI E E，LOW J G.Asymptomatic SARS-CoV-2 infection［J］．Lancet Infect Dis，2020，20（9）：996-998．DOI：10.1016/s1473-3099（20）30460-6.
［7］MIZUMOTO K，KAGAYA K，ZAREBSKI A，et al．Estimating the asymptomatic proportion of coronavirus disease 2019 （COVID-19） cases on board the Diamond Princess cruise ship，Yokohama，Japan，2020［J］．Eur Commun Dis Bull，2020，25（10）：2000180．DOI：10.2807/1560-7917.ES.2020.25.10.2000180.
［8］HOXHA A，WYNDHAM-THOMAS C，KLAMER S，et al．Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities［J］．Lancet Infect Dis，2020：S1473-S3099（20）30560-0．DOI：10.1016/S1473-3099（20）30560-0.
［9］BI Q F，WU Y S，MEI S J，et al．Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen，China：a retrospective cohort study［J］．Lancet Infect Dis，2020，20（8）：911-919．DOI：10.1016/S1473-3099（20）30287-5.
［10］SUTTON D，FUCHS K，D'ALTON M，et al．Universal screening for SARS-CoV-2 in women admitted for delivery［J］．N Engl J Med，2020，382（22）：2163-2164．DOI：10.1056/NEJMc2009316.
［11］WU Z Y，MCGOOGAN J M.Characteristics of and important lessons from the coronavirus disease 2019 （COVID-19） outbreak in China：summary of a report of 72?314 cases from the Chinese center for disease control and prevention［J］．JAMA，2020，323（13）：1239-1242．DOI：10.1001/jama.2020.2648.
［12］MEYEROWITZ E A，RICHTERMAN A，BOGOCH I I，et al．Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2［J］．Lancet Infect Dis，2020：S1473-S3099（20）30837-9．DOI：10.1016/S1473-3099（20）30837-9.
［13］RAHIMI F，TALEBI BEZMIN ABADI A.Challenges of managing the asymptomatic carriers of SARS-CoV-2［J］．Travel Med Infect Dis，2020，37：101677．DOI：10.1016/j.tmaid.2020.101677.
［14］ZOU L R，RUAN F，HUANG M X，et al．SARS-CoV-2 viral load in upper respiratory specimens of infected patients［J］．N Engl J Med，2020，382（12）：1177-1179．DOI：10.1056/NEJMc2001737.
［15］ROTHE C，SCHUNK M，SOTHMANN P，et al．Transmission of 2019-nCoV infection from an asymptomatic contact in Germany［J］．N Engl J Med，2020，382（10）：970-971．DOI：10.1056/NEJMc2001468.
［16］SAYAMPANATHAN A A，HENG C S，PIN P H，et al．Infectivity of asymptomatic versus symptomatic COVID-19［J］．Lancet，2020：S0140-S6736（20）32651-9．DOI：10.1016/S0140-6736（20）32651-9.
［17］ORAN D P，TOPOL E J.Prevalence of asymptomatic SARS-CoV-2 infection：a narrative review［J］．Ann Intern Med，2020，173（5）：362-367．DOI：10.7326/M20-3012.
［18］NISHIURA H，KOBAYASHI T，MIYAMA T，et al．Estimation of the asymptomatic ratio of novel coronavirus infections （COVID-19）［J］．Int J Infect Dis，2020，94：154-155．DOI：10.1016/j.ijid.2020.03.020.
［19］AL-QAHTANI M，ALALI S，ABDULRAHMAN A，et al．The prevalence of asymptomatic and symptomatic COVID-19 in a cohort of quarantined subjects［J］．Int J Infect Dis，2020，102：285-288．DOI：10.1016/j.ijid.2020.10.091.
［20］BAI Y，YAO L S，WEI T，et al．Presumed asymptomatic carrier transmission of COVID-19［J］．JAMA，2020，323（14）：1406-1407．DOI：10.1001/jama.2020.2565.
［21］WONG J，JAMALUDIN S A，ALIKHAN M F，et al．Asymptomatic transmission of SARS-CoV-2 and implications for mass gatherings［J］．Influenza Other Respir Viruses，2020，14（5）：596-598．DOI：10.1111/irv.12767.
［22］PAN X F，CHEN D X，XIA Y，et al．Asymptomatic cases in a family cluster with SARS-CoV-2 infection［J］．Lancet Infect Dis，2020，20（4）：410-411．DOI：10.1016/S1473-3099（20）30114-6.
［23］国务院应对新型冠状病毒肺炎疫情联防联控机制综合组.新冠病毒无症状感染者管理规范［EB/OL］．（2020-04-06）［2020-12-23］．http：//www.nhc.gov.cn/jkj/s7916/202004/9d3edaaebb9a4c369f42c61039be35fe.shtml.
［24］GUAN W J，NI Z Y，HU Y，et al．Clinical Characteristics of Coronavirus Disease 2019 in China ［J］．N Engl J Med，2020 Apr 30；382（18）：1708-1720．DOI：10.1056/NEJMoa2002032.
［25］BURKE R M，KILLERBY M E，NEWTON S，et al．Symptom profiles of a convenience sample of patients with COVID-19 - United States，January-April 2020［J］．MMWR Morb Mortal Wkly Rep，2020，69（28）：904-908．DOI：10.15585/mmwr.mm6928a2.
［26］PAN L，MU M，YANG P C，et al．Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei，China：a descriptive，cross-sectional，multicenter study［J］．Am J Gastroenterol，2020，115（5）：766-773．DOI：10.14309/ajg.0000000000000620.
［27］European Centre for Disease Prevention and Control.Case definition for coronavirus disease 2019 （COVID-19）［EB/OL］．（2020-12-03）［2020-12-23］．https：//www.ecdc.europa.eu/en/covid-19/surveillance/case-definition.
［28］WHO.WHO COVID-19 Case definition［EB/OL］．（2020-08-07）［2020-12-23］．https：//www.who.int/publications/i/item/WHO-2019-nCoV-Surveillance_Case_Definition-2020.1.
［29］Centers of Disease Control and Prevention.Coronavirus Disease 2019 （COVID-19）［EB/OL］．（2020-08-05）［2020-12-23］．https：//wwwn.cdc.gov/nndss/conditions/coronavirus-disease-2019-covid-19/case-definition/2020/08/05/.
［30］Ministry of Health and Ministry of Long-Term Care.Case Definition - Coronavirus Disease （COVID-19）［EB/OL］．（2020-12-01）［2020-12-23］．http：//www.health.gov.on.ca/en/pro/programs/publichealth/coronavirus/docs/2019_case_definition.pdf.
［31］YI Y，LAGNITON P N P，YE S，et al．COVID-19：what has been learned and to be learned about the novel coronavirus disease［J］．Int J Biol Sci，2020，16（10）：1753-1766．DOI：10.7150/ijbs.45134.
［32］Centers of Disease Control and Prevention.Pandemic Planning Scenarios ［EB/OL］．（2020-06-23）［2020-12-23］．https：//www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html.
［33］NG Y，LI Z B，CHUA Y X，et al．Evaluation of the effectiveness of surveillance and containment measures for the first 100 patients with COVID-19 in Singapore - January 2-February 29，2020［J］．MMWR Morb Mortal Wkly Rep，2020，69（11）：307-311．DOI：10.15585/mmwr.mm6911e1.
［34］Emerging COVID-19 success story：South Korea learned the lessons of MERS ［EB/OL］．（2020-6-30）［2020-12-23］．https：//ourworldindata.org/covid-exemplar-south-korea.
［35］SKITTRALL J P，FORTUNE M D，JALAL H，et al．Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols［J］．Lancet Reg Heal - Eur，2020：100002．DOI：10.1016/j.lanepe.2020.100002.
［36］HUNG I F，CHENG V C，LI X，et al．SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship：a case series［J］．Lancet Infect Dis，2020，20（9）：1051-1060．DOI：10.1016/S1473-3099（20）30364-9.
［37］TEHERáN A A，CAMERO RAMOS G，PRADO DE LA GUARDIA R，et al．Epidemiological characterisation of asymptomatic carriers of COVID-19 in Colombia：a cross-sectional study［J］．BMJ Open，2020，10（12）：e042122．DOI：10.1136/bmjopen-2020-042122.
［38］ZHOU F L，LI J F，LU M X，et al．Tracing asymptomatic SARS-CoV-2 carriers among 3674 hospital staff：a cross-sectional survey［J］．EClinicalMedicine，2020，26：100510．DOI：10.1016/j.eclinm.2020.100510.
［39］CORMAN V M，LANDT O，KAISER M，et al．Detection of 2019 novel coronavirus （2019-nCoV） by real-time RT-PCR［J］．Eur Commun Dis Bull，2020，25（3）：2000045．DOI：10.2807/1560-7917.ES.2020.25.3.2000045.
［40］LOHSE S，PFUHL T，BERKó-G?TTEL B，et al．Pooling of samples for testing for SARS-CoV-2 in asymptomatic people［J］．Lancet Infect Dis，2020，20（11）：1231-1232．DOI：10.1016/S1473-3099（20）30362-5.
［41］LECHIEN J R，CHIESA-ESTOMBA C M，DE SIATI D R，et al．
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease （COVID-19）：a multicenter European study［J］．Eur Arch Otorhinolaryngol，2020，277（8）：2251-2261．DOI：10.1007/s00405-020-05965-1.
［42］MOEIN S T，HASHEMIAN S M，MANSOURAFSHAR B，et al．Smell dysfunction：a biomarker for COVID-19［J］．Int Forum Allergy Rhinol，2020，10（8）：944-950．DOI：10.1002/alr.22587.
［43］LI J W，LONG X，ZHU C L，et al．Olfactory dysfunction in recovered coronavirus disease 2019 （COVID-19） patients［J］．Mov Disord，2020，35（7）：1100-1101．DOI：10.1002/mds.28172.
［44］CHEN M F，SHEN W J，ROWAN N R，et al．Elevated ACE-2 expression in the olfactory neuroepithelium：implications for anosmia and upper respiratory SARS-CoV-2 entry and replication［J］．Eur Respir J，2020，56（3）：2001948．DOI：10.1183/13993003.01948-2020.
［45］LI J W，WANG X Y，ZHU C L，et al．Affected olfaction in COVID-19：Re-defining “asymptomatic”［J］．EClinicalMedicine，2020，29：100628．DOI：10.1016/j.eclinm.2020.100628.
［46］BHATTACHARJEE A S，JOSHI S V，NAIK S，et al．Quantitative assessment of olfactory dysfunction accurately detects asymptomatic COVID-19 carriers［J］．EClinicalMedicine，2020，28：100575．DOI：10.1016/j.eclinm.2020.100575.
［47］Emerging COVID-19 success story：Germany's strong enabling environment［EB/OL］．（2020-06-30）［2020-12-23］．https：//ourworldindata.org/covid-exemplar-germany.

[1]	YANG Hui, HU Ruwei, LIU Ruqing, LU Junfeng, WU Jinglan. Relationship between Community Health Service Experience and Glycemic Control Outcomes in Patients with Diabetes Mellitus [J]. Chinese General Practice, 2023, 26(34): 4290-4295.
[2]	MA Liyuan, WANG Zengwu, FAN Jing, HU Shengshou. Interpretation of Report on Cardiovascular Health and Diseases in China 2022 [J]. Chinese General Practice, 2023, 26(32): 3975-3994.
[3]	HE Jingyi, WANG Fang, SHUI Xiaoling, LI Ling, LIANG Qian. Efficacy of Non-pharmacological Interventions to Improve Perimenopausal Insomnia Symptoms: a Network Meta-analysis [J]. Chinese General Practice, 2023, 26(31): 3963-3974.
[4]	QU Hui, LI Huan, TANG Ruohan, DU Yuzheng, ZHAO Qi. Outcome Indicators Analysis of Randomized Controlled Trials of Acupuncture for Obstructive Sleep Apnea Hypopnea Syndrome in the Past Decade [J]. Chinese General Practice, 2023, 26(30): 3734-3739.
[5]	WEN Wen, ZHANG Kainan, CHEN Yulan, LI Yu, ZHANG Xiangyang. Correlation of Metabolic Indexes as Predictors with Obstructive Sleep Apnea [J]. Chinese General Practice, 2023, 26(30): 3740-3747.
[6]	CHENG Xiaoran, ZHANG Xiaotian, LI Mingyue, CHENG Haozhe, TANG Haoqing, ZHENG Huixian, ZHANG Baisong, LIU Xiaoyun. Impact of Chronic Diseases Follow-up on Health Behaviors and Blood Pressure/Glucose Control of Patients with Hypertension and Diabetes in the Context of Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(28): 3482-3488.
[7]	Expert group of expert consensus on the application of ulinastatin in common clinical critical illness. Expert Consensus on the Application of Ulinastatin in Common Clinical Critical Illness [J]. Chinese General Practice, 2023, 26(26): 3207-3219.
[8]	LIU Jian, ZHANG Tianyi, AILIZHATI ·Aizezi, CHANG Ruijing, ZHANG Jianli, WANG Wan, JIANG Peng. Cardiopulmonary Physiology Effects of Wearing a Surgical Mask Versus an N95 Respirator in Patients with COPD during Walking: a Randomized Crossover Controlled Trial [J]. Chinese General Practice, 2023, 26(24): 3028-3032.
[9]	ZUO Xu, HUANG Zhaolan, LU Biao. Differences between the First and Another 3-day Blood Pressure Levels and Associated Factors in a Self-reported Non-hypertensive Population Aged 35-64 Years [J]. Chinese General Practice, 2023, 26(22): 2771-2777.
[10]	WU Jian, YU Chengcheng, YANG Yinmei, XIA Qingyun, LI Quanman, FU Xiaoli. COVID-19 Vaccination Behavior and Its Influencing Factors among the Elderly in Four Regions of China [J]. Chinese General Practice, 2023, 26(22): 2763-2770.
[11]	YANG Hui. Cooperated and Shared Care: Reflections on Treatment-prevention Integration [J]. Chinese General Practice, 2023, 26(22): 2711-2714.
[12]	HE Manlan, YUAN Ping, HE Lei, CHEN Lu. Meta-analysis of Risk Factors for Urinary Tract Infection in Neurogenic Bladder [J]. Chinese General Practice, 2023, 26(21): 2659-2665.
[13]	HE Mei, LI Hui, MU Lifeng, YANG Ming. Effect of Azovudine on Hepatic and Renal Function in Patients with COVID-19: a Case Series Study [J]. Chinese General Practice, 2023, 26(20): 2476-2481.
[14]	XUE Shan, LI Laiyou, LIANG Junli, JIN Yinghui, WEI Shuyan. The Efficacy and Safety of Home Enteral Nutrition in Patients with Esophageal Cancer: a Meta-analysis [J]. Chinese General Practice, 2023, 26(20): 2540-2547.
[15]	WANG Shumin, LI Xuejun, ZHANG Yixing, JIANG Zhiyan, XIAO Zhen. Correlation between Mycoplasma Pneumoniae Infection and Coronary Artery Lesions in Mucocutaneous Lymph Node Syndrome: a Meta-analysis [J]. Chinese General Practice, 2023, 26(20): 2532-2539.